LOS ANGELES, Oct. 21, 2019 (GLOBE NEWSWIRE) -- OG DNA Genetics (“DNA” or the “Company”), a globally recognized leading cannabis brand, announced that Charles Phillips, Chief Executive Officer, will be a guest speaker at this year’s Benzinga Cannabis Capital Conference held in Chicago at the Palmer House Hotel from October 22 – 23, 2019.
The Benzinga Cannabis Capital Conference is the premier gathering of cannabis entrepreneurs and investors in North America. No other conference offers the level of access and seamlessness of interaction between entrepreneurs building future billion-dollar cannabis enterprises and the investors whose capital will make that happen. Mr. Phillips’ will discuss how DNA Genetics’ brand awareness and award-winning cannabis strains ensure high-yield production, pharmacological efficacy and heightened consumer interest, making partnership and investment with DNA Genetics extremely valuable. Mr. Phillips presentation will take place on October 23rd at 10:30 a.m. CST.
After spending over a decade building their brand in the European marketplace, DNA established themselves as one of the most respected and well regarded cannabis brands in the world with licensing deals across the globe. For more than 15 years, DNA’s strains have won over 200 awards in all categories at cannabis events around the world, making DNA the global standard in breeding and growing.
Mr. Phillips joins DNA at a pivotal time in the company’s history as they position the legacy brand for public offering. Mr. Phillips began his career as an Associate at The Boston Consulting Group, receiving his bachelor’s degree in Government from Harvard University, and his Master of Business Administration from Stanford Graduate School of Business. He ran business development from 2017-18 at Harborside Health, a major cannabis retailer in Oakland, before joining DNA Genetics. Along with Mr. Phillips contributions to the growth of the DNA brand, he helped to successfully close the first two equity financings in the history of the company, bringing in an aggregate of US$35 million from a strong group of institutional and strategic investors.
About OG DNA Genetics Inc.
DNA was rooted in Los Angeles and founded in Amsterdam in 2004 by Don Morris and Aaron Yarkoni. Over the last decade, the Company has built and curated a seasoned genetic library and developed proven standard operating procedures for genetic selection, breeding, and cultivation. In a world that is increasingly opening up to commercial cannabis activity, DNA is positioned to become the first, truly geographically-diversified company with multiple partnerships with top-licensed producers and brands that have built their companies and global presence utilizing the “Powered by DNA” model. For more information, please visit www.dnagenetics.com.
For further information, please contact Rezwan Khan, Vice President, Global Corporate Development at Rezwan@dnagenetics.com